BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shen Y, Wang X, Zhang S, Qin G, Liu Y, Lu Y, Liang F, Zhuang X. A comprehensive validation of HBV-related acute-on-chronic liver failure models to assist decision-making in targeted therapeutics. Sci Rep 2016;6:33389. [PMID: 27633520 DOI: 10.1038/srep33389] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Huang K, Ji F, Xie Z, Wu D, Xu X, Gao H, Ouyang X, Xiao L, Zhou M, Zhu D, Li L. Artificial liver support system therapy in acute-on-chronic hepatitis B liver failure: Classification and regression tree analysis. Sci Rep 2019;9:16462. [PMID: 31712684 DOI: 10.1038/s41598-019-53029-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
2 Liu L, Lan Q, Lin L, Lu J, Ye C, Tao Q, Cui M, Zheng S, Zhang X, Xue Y. Gamma-glutamyl transpeptidase-to-platelet ratio predicts the prognosis in HBV-associated acute-on-chronic liver failure. Clin Chim Acta 2018;476:92-7. [PMID: 29170103 DOI: 10.1016/j.cca.2017.11.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]